[fcb5af]: / literature / by_gene / P2RY8.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34857887 10.1038/s41388-021-02126-4 2022 HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. P2RY8
2 35484080 10.1016/j.clml.2022.03.007 2022 Clinico-hematological and Outcome Profile of Pediatric B-other-ALL and BCR::ABL1-like pre-B-ALL: An Integrated Genomic Study From North India. P2RY8
3 35537330 10.1016/j.cyto.2022.155896 2022 High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia. P2RY8
4 35912172 10.3389/fonc.2022.896858 2022 Recurrent Novel <i>P2RY8/IGH</i> Translocations in B-Lymphoblastic Leukemia/Lymphoma. P2RY8
5 36076986 10.3390/ijms23179587 2022 Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients. P2RY8
6 33615710 10.1111/ijlh.13419 2021 Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensitivities of Nalm6 cells. P2RY8
7 33707599 10.1038/s41598-021-85213-6 2021 Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan. P2RY8
8 33750258 10.1080/0284186X.2021.1900908 2021 Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype. P2RY8
9 33781217 10.1186/s12885-020-07781-6 2021 Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach - a population-based study. P2RY8
10 33812392 10.19746/j.cnki.issn.1009-2137.2021.02.001 2021 [Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement]. P2RY8
11 33890726 10.1002/cjp2.211 2021 CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways. P2RY8
12 34159401 10.1007/s00277-021-04574-0 2021 Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. P2RY8
13 34732618 10.11406/rinketsu.62.1465 2021 [Down syndrome and acute lymphoblastic leukemia]. P2RY8
14 33113607 10.3760/cma.j.issn.0253-2727.2020.09.008 2020 [Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization]. P2RY8
15 30842656 10.1038/s41586-019-1003-z 2019 S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. P2RY8
16 30859636 10.1002/gcc.22748 2019 GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia. P2RY8
17 29194562 10.1111/bjh.15056 2018 A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children. P2RY8
18 29407587 10.1016/j.leukres.2018.01.012 2018 High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction. P2RY8
19 29507076 10.1182/bloodadvances.2017014704 2018 Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. P2RY8
20 29786757 10.1007/s12185-018-2474-7 2018 Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes. P2RY8
21 29982439 10.1093/gigascience/giy079 2018 Clinker: visualizing fusion genes detected in RNA-seq data. P2RY8
22 27637012 10.1002/gcc.22421 2017 Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia. P2RY8
23 27855558 10.1080/10428194.2016.1219902 2017 Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). P2RY8
24 27899802 10.1038/leu.2016.365 2017 Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia. P2RY8
25 28033648 10.1002/gcc.22439 2017 Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia. P2RY8
26 28371317 10.1002/pbc.26539 2017 Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood. P2RY8
27 28395118 10.1002/gcc.22464 2017 ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. P2RY8
28 28408464 10.1182/blood-2016-12-758979 2017 Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. P2RY8
29 28866095 10.1016/j.canlet.2017.08.034 2017 Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. P2RY8
30 29140408 10.1093/ajcp/aqx111 2017 Philadelphia Chromosome-like Mixed-Phenotype Acute Leukemia Demonstrating P2RY8-CRLF2 Fusion and JAK1 Mutation. P2RY8
31 26754556 10.1016/j.leukres.2015.11.018 2016 CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. P2RY8
32 27161658 10.1016/j.jmoldx.2016.03.004 2016 Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/Lymphoma. P2RY8
33 27959929 10.1371/journal.pmed.1002197 2016 Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. P2RY8
34 26018335 10.1111/bjh.13514 2015 The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. P2RY8
35 23911702 10.3324/haematol.2013.090225 2014 High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. P2RY8
36 24935070 10.1002/gcc.22190 2014 An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression. P2RY8
37 25044358 10.1002/gcc.22201 2014 Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan. P2RY8
38 25105841 10.1038/ncomms5654 2014 Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. P2RY8
39 25274307 10.1038/nature13765 2014 Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. P2RY8
40 22875627 10.3324/haematol.2011.056135 2013 IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. P2RY8
41 23145900 10.1111/bjh.12130 2013 No prognostic impact of P2RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia. P2RY8
42 23212523 10.1182/blood-2012-04-422691 2013 Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. P2RY8
43 23930217 10.1002/cam4.87 2013 IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. P2RY8
44 22072402 10.1002/gcc.20944 2012 High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome. P2RY8
45 22343534 10.1073/pnas.1121343109 2012 Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. P2RY8
46 22368272 10.1182/blood-2011-11-394221 2012 Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. P2RY8
47 22484421 10.1038/leu.2012.101 2012 Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. P2RY8
48 22816614 10.1111/j.1365-2141.2012.09221.x 2012 Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups. P2RY8
49 22851563 10.1200/JCO.2011.40.3907 2012 IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. P2RY8
50 23091296 10.1182/blood-2012-07-443218 2012 Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. P2RY8
51 21106984 10.1182/blood-2010-07-297135 2011 Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. P2RY8
52 21527530 10.1182/blood-2011-01-329961 2011 Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. P2RY8
53 19965641 10.1182/blood-2009-08-235408 2010 Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. P2RY8
54 20139093 10.1182/blood-2009-09-245944 2010 Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. P2RY8
55 20378752 10.1182/blood-2009-11-256131 2010 Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. P2RY8
56 20847213 10.1182/blood-2010-05-286492 2010 t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. P2RY8
57 19838194 10.1038/ng.469 2009 Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. P2RY8
58 17487742 10.1080/10428190701225882 2007 Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening. P2RY8
59 17554380 10.1038/sj.leu.2404784 2007 Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. P2RY8